For example, Fu et al. proved that JMJD2B can be combined with HIF-1α to reduce H3K9me3 on the promoter of HIF-1α-targeted genes to upregulate their expression and to contribute to the malignant phenotype of CRC [170]. This evidence concerns the gene HIF1A and colorectal carcinoma.